Perelman Professorship in Cancer Biology

perelman photoIn 2011, Ray and Ruth Perelman made a historic gift to permanently endow Penn’s medical school, which was renamed the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania. From the endowment funds, Perelman Professorships were created to recognize faculty members who are making a transformative impact on academic medicine. Perelman Professorships are awarded to both current Penn professors and new faculty recruited from around the world.  

The Perelmans’ endowment of the medical school followed the couple’s earlier naming gift for the Ruth and Raymond Perelman Center for Advanced Medicine, Penn Medicine’s state-of-the-art outpatient center. Through their philanthropy, the Perelmans became crucial partners in making Penn Medicine one of the most influential and innovative academic medical centers in the U.S. 

Raymond G. Perelman (1917–2019) was the Founder, Chairman, and CEO of RGP Holdings, a private holding company comprising an array of manufacturing, mining, and financial interests. He and Ruth Caplan Perelman (1921– 2011) were married for 70 years. The Perelmans were counted among Philadelphia’s most prominent and generous philanthropists. They made pathbreaking gifts to the Philadelphia Museum of Art and its adjacent Perelman Building, the Kimmel Center and Perelman Theater, the Perelman Jewish Day School, and many other Jewish cultural and welfare organizations. Both the Children’s Hospital of Philadelphia and Drexel University have honored Ray’s extraordinary support by naming areas of their campuses in his honor.    

At Penn, Mr. Perelman became a powerful advocate for all of Penn Medicine’s missions. In his later years, he could often be seen on campus or at medical school events such as graduation and the celebration of the Perelman School of Medicine’s 250th year. He particularly enjoyed meeting Penn’s incoming medical students. 

A Wharton alumnus and recipient of an Honorary Doctor of Laws degree from Penn, he served as a Penn Medicine Trustee from 2002 to 2012. In 2011, he was awarded Penn’s Medal for Distinguished Achievement, one of the University’s highest honors, to recognize “his untiring efforts and immeasurable contributions to the health and well-being, education and cultural opportunities in Philadelphia and beyond.” 


 

chodosh photoCurrent Chairholder

Lewis A. Chodosh, PhD

In addition to holding the Perelman Chair, Dr. Chodosh is also Associate Director for Basic Science, Abramson Cancer Center; Co-Director, 2-PREVENT Translational Center of Excellence; and Investigator, Abramson Family Cancer Research Institute.

The Chodosh laboratory uses genetically engineered mouse models, patient samples and bioinformatics to understand the mechanisms by which cancers develop, progress to more aggressive states, and ultimately contribute to cancer mortality. A broad array of basic and translational research approaches are used to address problems of fundamental clinical importance to cancer patients by elucidating pathways and principles common to human cancers. These approaches encompass genetics, genomics, molecular biology, biochemistry, cell biology, computational biology, functional imaging, animal studies, preclinical trials and clinical investigation.

Particular areas of interest include: pathways regulating cancer development, metastasis, tumor dormancy and recurrence; the use of genomics and computational approaches to understand genetic programs in cancer; the impact of obesity on cancer recurrence; the mechanisms by which pregnancy protects against breast cancer; and the use of non-invasive imaging approaches to study tumor biology.

Dr. Chodosh received his PhD in biochemistry from MIT and his MD from Harvard Medical School.